1.6500
-0.1500
(-8.33%)
At close: January 10 at 4:00:02 PM EST
1.8400
+0.19
+(11.52%)
After hours: January 10 at 7:52:14 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHIN MARK Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 18,306 |
| DUNNE MICHAEL W Director | Conversion of Exercise of derivative security | Aug 6, 2024 | 220,001 |
| FISHMAN COREY N Chief Executive Officer | Conversion of Exercise of derivative security | Aug 6, 2024 | 137,062 |
| HECHT BETH P Director | Conversion of Exercise of derivative security | Jun 15, 2023 | 18,839 |
| HUNT RONALD M Director | Conversion of Exercise of derivative security | Aug 6, 2024 | -- |
| MATTHEWS JUDITH M Chief Financial Officer | Conversion of Exercise of derivative security | Mar 10, 2023 | 8,135 |
| PUTTAGUNTA SAILAJA Officer | Conversion of Exercise of derivative security | Dec 1, 2023 | 10,369 |
Related Tickers
SPRO Spero Therapeutics, Inc.
0.9800
-2.00%
MIST Milestone Pharmaceuticals Inc.
2.0800
-5.45%
LPCN Lipocine Inc.
4.8900
-6.50%
CNSP CNS Pharmaceuticals, Inc.
0.1178
+1.55%
JAGX Jaguar Health, Inc.
1.0000
-8.26%
CARA Cara Therapeutics, Inc.
4.7500
0.00%
EQ Equillium, Inc.
0.7006
-2.21%
VYNE VYNE Therapeutics Inc.
3.4300
-12.50%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%
IBIO iBio, Inc.
2.5500
-6.25%